Bhanvi
@bhanvi16.bsky.social
Covering U.S. health & pharma at Reuters | Views my own etc.
Reposted by Bhanvi
Kennedy's key vaccine panel down to 7 members ahead of first meeting, NYT reports reut.rs/44gVvHE
Kennedy's key vaccine panel down to 7 members ahead of first meeting, NYT reports
A key panel of vaccine advisers named by U.S. Health Secretary Robert Kennedy Jr. earlier this month is now down to seven members from the earlier announced strength of eight after one of the members opted out ahead of the committee's first meeting, the New York Times reported on Tuesday.
reut.rs
June 25, 2025 at 4:00 AM
Kennedy's key vaccine panel down to 7 members ahead of first meeting, NYT reports reut.rs/44gVvHE
US Health Secretary Kennedy guts vaccine advisory committee in what is the most far reaching move yet to reshape the regulation of vaccines
Read more from my colleagues on @reuters.com
www.reuters.com/business/hea...
Read more from my colleagues on @reuters.com
www.reuters.com/business/hea...
US health secretary Kennedy to remove all CDC outside experts on vaccines
Health Secretary Robert F. Kennedy Jr. is getting rid of all members sitting on a key U.S. Centers for Disease Control and Prevention panel of vaccine experts and reconstituting the committee, he said on Monday.
www.reuters.com
June 10, 2025 at 7:48 AM
US Health Secretary Kennedy guts vaccine advisory committee in what is the most far reaching move yet to reshape the regulation of vaccines
Read more from my colleagues on @reuters.com
www.reuters.com/business/hea...
Read more from my colleagues on @reuters.com
www.reuters.com/business/hea...
Trump's federal health agency cuts have sent shivers through a biotech industry already struggling with a prolonged downturn, increasing concerns they will have a harder time getting products approved, investors, company execs & analysts said.
Story for @reuters.com with my colleague Maggie Fick
Story for @reuters.com with my colleague Maggie Fick
Trump health policy uncertainty sends biotech sector into deeper slump
Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they will have a harder time getting products approved, investors, company executives and analysts said.
www.reuters.com
April 14, 2025 at 6:44 PM
Trump's federal health agency cuts have sent shivers through a biotech industry already struggling with a prolonged downturn, increasing concerns they will have a harder time getting products approved, investors, company execs & analysts said.
Story for @reuters.com with my colleague Maggie Fick
Story for @reuters.com with my colleague Maggie Fick
A New Mexico resident who has died, tested positive for measles, according to the state health department, marking the second measles-related death in US in over a decade.
The death brings to ten the number of measles cases that occurred in Lea County.
Read more on @reuters.com
The death brings to ten the number of measles cases that occurred in Lea County.
Read more on @reuters.com
Deceased New Mexico resident tests positive for measles, health department says
A deceased resident of Lea County in New Mexico tested positive for measles, the state health department said on Thursday, even though the cause of death was still being investigated.
www.reuters.com
March 7, 2025 at 1:14 PM
A New Mexico resident who has died, tested positive for measles, according to the state health department, marking the second measles-related death in US in over a decade.
The death brings to ten the number of measles cases that occurred in Lea County.
Read more on @reuters.com
The death brings to ten the number of measles cases that occurred in Lea County.
Read more on @reuters.com
A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the month has been postponed, the U.S. Food and Drug Administration's website showed on Friday.
www.reuters.com/business/hea...
www.reuters.com/business/hea...
US health agencies postpone rare diseases event in an unusual move
A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the month has been postponed, the U.S. Food and Drug Administration's website showed on Friday.
www.reuters.com
February 22, 2025 at 6:46 AM
A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the month has been postponed, the U.S. Food and Drug Administration's website showed on Friday.
www.reuters.com/business/hea...
www.reuters.com/business/hea...
About a dozen companies are testing weight-loss treatments aimed at preserving muscle, and analysts, clinical trial experts and doctors say they may also need to show benefits beyond the numbers on a scale to get approved.
My latest for @reuters.com with the wonderful @ludwigburger.bsky.social
My latest for @reuters.com with the wonderful @ludwigburger.bsky.social
New weight loss drugs aim to save muscle
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, clinical trial experts and doctors say they may also need to demonstrate additional health benefits beyond the numbers on a scale to get approved.
www.reuters.com
February 19, 2025 at 9:23 PM
About a dozen companies are testing weight-loss treatments aimed at preserving muscle, and analysts, clinical trial experts and doctors say they may also need to show benefits beyond the numbers on a scale to get approved.
My latest for @reuters.com with the wonderful @ludwigburger.bsky.social
My latest for @reuters.com with the wonderful @ludwigburger.bsky.social
Reposted by Bhanvi
Indian book publishers and their international counterparts have filed a copyright lawsuit against OpenAI in New Delhi, a representative said, the latest in a series of cases seeking to stop the ChatGPT chatbot accessing proprietary content reut.rs/40vWqBR
OpenAI faces new copyright case, from global book publishers in India
Indian book publishers and their international counterparts have filed a copyright lawsuit against OpenAI in New Delhi, a representative said on Friday, the latest in a series of global cases seeking to stop the ChatGPT chatbot accessing proprietary content.
reut.rs
January 24, 2025 at 3:02 PM
Indian book publishers and their international counterparts have filed a copyright lawsuit against OpenAI in New Delhi, a representative said, the latest in a series of cases seeking to stop the ChatGPT chatbot accessing proprietary content reut.rs/40vWqBR
Reposted by Bhanvi
Reposted by Bhanvi
Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from Sanofi at the start of 2025, as per data analyzed by a healthcare research firm reut.rs/4gxJqTh
Drugmakers to raise US prices on over 250 medicines starting Jan. 1
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from France's Sanofi at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors.
reut.rs
December 31, 2024 at 4:45 PM
Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from Sanofi at the start of 2025, as per data analyzed by a healthcare research firm reut.rs/4gxJqTh
U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research.
Story for @reuters.com
Story for @reuters.com
Retail investors buy Novo dip after disappointing weight-loss drug data
U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research.
www.reuters.com
December 24, 2024 at 7:54 PM
U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research.
Story for @reuters.com
Story for @reuters.com
While FDA’s finding that Lilly’s weight loss drug was no longer in shortage effectively bars widespread sales of cheaper copies, the agency will not take any action against the compounding pharmacies within 60 to 90 days of the decision.
Story for @reuters.com
Story for @reuters.com
US FDA says Lilly's weight-loss drug shortage is resolved
The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly's blockbuster weight loss and diabetes drugs following a re-evaluation of their supply by the agency.
www.reuters.com
December 19, 2024 at 8:59 PM
While FDA’s finding that Lilly’s weight loss drug was no longer in shortage effectively bars widespread sales of cheaper copies, the agency will not take any action against the compounding pharmacies within 60 to 90 days of the decision.
Story for @reuters.com
Story for @reuters.com
Reposted by Bhanvi
A growing coalition of health and consumer advocates is campaigning against Robert F. Kennedy Jr.'s nomination to the top US health job over concerns about his activism against vaccines and other health issues reut.rs/41y1XKz
Kennedy opposed by advocates for US health post
An expanding coalition of health and consumer advocates is campaigning against Robert F. Kennedy Jr.'s nomination to the top U.S. health job over concerns about his activism against vaccines and other health issues, according to the groups' representatives.
reut.rs
December 16, 2024 at 10:01 PM
A growing coalition of health and consumer advocates is campaigning against Robert F. Kennedy Jr.'s nomination to the top US health job over concerns about his activism against vaccines and other health issues reut.rs/41y1XKz
Reposted by Bhanvi
In the days since Luigi Mangione was named a suspect in the murder of a top US health insurance executive, more than a thousand donations have poured into an online fundraiser for his legal defense, with messages supporting him and even celebrating the crime reut.rs/4iAnVT0
Luigi Mangione was charged with murder - then donations started pouring in
Most of the messages on the crowd-sourced fundraising site GiveSendGo reflect a deep frustration shared by many Americans over the U.S. healthcare system.
reut.rs
December 12, 2024 at 5:21 PM
In the days since Luigi Mangione was named a suspect in the murder of a top US health insurance executive, more than a thousand donations have poured into an online fundraiser for his legal defense, with messages supporting him and even celebrating the crime reut.rs/4iAnVT0
Reposted by Bhanvi
New York prosecutors filed a murder charge against Luigi Mangione, the suspect in the killing of UnitedHealth executive Brian Thompson, a brazen shooting that set off a manhunt that culminated in his capture in Pennsylvania reut.rs/3D7Hsu2
Suspect in killing of UnitedHealth executive Brian Thompson charged with murder
New York prosecutors filed a murder charge against the suspect in the killing of a UnitedHealth executive, a brazen shooting that set off a manhunt that culminated in his capture in Pennsylvania earlier on Monday.
reut.rs
December 10, 2024 at 4:07 AM
New York prosecutors filed a murder charge against Luigi Mangione, the suspect in the killing of UnitedHealth executive Brian Thompson, a brazen shooting that set off a manhunt that culminated in his capture in Pennsylvania reut.rs/3D7Hsu2
Reposted by Bhanvi
General Motors said it will end robotaxi development at its majority-owned, money-losing Cruise business, a blow to the ambitions of the largest US automaker which had made the advanced technology unit a top priority reut.rs/3OPZBPB
GM to exit loss-making Cruise robotaxi business
General Motors said on Tuesday it will end robotaxi development at its majority-owned, money-losing Cruise business, a blow to the ambitions of the largest U.S. automaker which had made the advanced technology unit a top priority.
reut.rs
December 11, 2024 at 3:43 AM
General Motors said it will end robotaxi development at its majority-owned, money-losing Cruise business, a blow to the ambitions of the largest US automaker which had made the advanced technology unit a top priority reut.rs/3OPZBPB
Reposted by Bhanvi
#UNH #UnitedHealth suspect in custody after being spotted by a #McDonald's employee in Pa.
(Not for nothing, but lowkey pretty eventful year for Mickey D's - presidential candidate who worked there, another did a strange photo op, e coli outbreak, now this)
www.reuters.com/world/us/inv...
(Not for nothing, but lowkey pretty eventful year for Mickey D's - presidential candidate who worked there, another did a strange photo op, e coli outbreak, now this)
www.reuters.com/world/us/inv...
Police questioning man found with gun about UnitedHealth exec killing, reports say
Authorities on Monday were questioning a man in central Pennsylvania in connection with last week's murder of UnitedHealthcare CEO Brian Thompson, several media outlets reported.
www.reuters.com
December 9, 2024 at 8:19 PM
#UNH #UnitedHealth suspect in custody after being spotted by a #McDonald's employee in Pa.
(Not for nothing, but lowkey pretty eventful year for Mickey D's - presidential candidate who worked there, another did a strange photo op, e coli outbreak, now this)
www.reuters.com/world/us/inv...
(Not for nothing, but lowkey pretty eventful year for Mickey D's - presidential candidate who worked there, another did a strange photo op, e coli outbreak, now this)
www.reuters.com/world/us/inv...
Reposted by Bhanvi
America's culture wars upend white-collar case: US judge rejects Boeing plea deal in fatal 737 MAX crashes, faulting a diversity and inclusion provision in the agreement. w/ Allison Lampert @davidshepardson.bsky.social @chrisprentice.bsky.social
www.reuters.com/legal/us-jud...
www.reuters.com/legal/us-jud...
US judge rejects Boeing plea deal in fatal crashes
A U.S. federal judge on Thursday rejected Boeing's agreement to plead guilty to fraud in the wake of two fatal 737 MAX crashes, court documents showed.
www.reuters.com
December 6, 2024 at 12:29 PM
America's culture wars upend white-collar case: US judge rejects Boeing plea deal in fatal 737 MAX crashes, faulting a diversity and inclusion provision in the agreement. w/ Allison Lampert @davidshepardson.bsky.social @chrisprentice.bsky.social
www.reuters.com/legal/us-jud...
www.reuters.com/legal/us-jud...
Reposted by Bhanvi
Armed with a growing file of clues, New York police on Friday were scouring surveillance videos and asking the public for help in their search for the masked assailant who gunned down a UnitedHealth executive on a Midtown Manhattan sidewalk.
www.reuters.com/world/us/pol...
www.reuters.com/world/us/pol...
Police scour New York for suspect two days after UnitedHealth executive gunned down
New York police were asking the public for help in their search for the masked assailant.
www.reuters.com
December 6, 2024 at 10:46 AM
Armed with a growing file of clues, New York police on Friday were scouring surveillance videos and asking the public for help in their search for the masked assailant who gunned down a UnitedHealth executive on a Midtown Manhattan sidewalk.
www.reuters.com/world/us/pol...
www.reuters.com/world/us/pol...
Reposted by Bhanvi
US President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid, which could cut out-of-pocket expenses for some by as much as 95% reut.rs/3OodB2V
Biden to propose expanded Medicare, Medicaid coverage of obesity drugs, official says
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid, which could cut out-of-pocket expenses for some by as much as 95%.
reut.rs
November 26, 2024 at 4:05 PM
US President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid, which could cut out-of-pocket expenses for some by as much as 95% reut.rs/3OodB2V
Amgen's experimental drug MariTide helped overweight or obese patients shed up to 20% of their body weight in a mid-stage trial, but the results failed to meet lofty investor expectations and shares of the biotech company tumbled about 12% on Tuesday.
Story for @reuters.com
Story for @reuters.com
Amgen's weight-loss drug fails to impress in study; shares plunge
Amgen's experimental drug MariTide helped overweight or obese patients shed up to 20% of their body weight in a mid-stage trial, but the results failed to meet lofty investor expectations and shares of the biotech company tumbled about 12% on Tuesday.
www.reuters.com
November 26, 2024 at 6:15 PM
Amgen's experimental drug MariTide helped overweight or obese patients shed up to 20% of their body weight in a mid-stage trial, but the results failed to meet lofty investor expectations and shares of the biotech company tumbled about 12% on Tuesday.
Story for @reuters.com
Story for @reuters.com